Further analysis with CellChat revealed that the CD72-APP signaling pathway between XPO high macrophages and endothelial cells contributed to ccRCC progression (Supporting Information 6: Figure S6(B)). This evidence concerns the gene CD72 and nonpapillary renal cell carcinoma.